Evaluating heparin preparations

US8435795B2 · kind B2 · utility

Assignee

• MOMENTA PHARMACEUTICALS, INC. · US

Inventors

• Daniela Beccati · Boston, US
• Ishan Capila · Ashland, US
• Nur Sibel Gunay · Brookline, US
• Sucharita Roy · Tyngsborough, US

Key dates

• Filing date: Jan 18, 2011
• Grant date: May 7, 2013
• Expiry date: Jan 20, 2031

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10T436/24
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods of evaluating heparin preparations, e.g., for suitability for use as a drug or for use in making a drug, by determining the absence, presence or amount of a structural signature that is indicative of the methods used to make the heparin preparation.